59.59 USD
↘ 0.41 (0.68%)AT CLOSE (11:59 AM EDT)
BioMarin Pharmaceuticals Inc
BMRNNASDAQ • USD
58.50
↘ 1.09 (1.83%)
POST MARKET (AS OF 07:18 PM EDT)
Post Market
AS OF 07:18 PM EDT
58.50
↘ 1.09 (1.83%)
Market: CLOSED
BMRN is currently priced at $59.58. Technicals currently rate "Buy" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score and a bullish Golden Cross on the moving averages. BMRN is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Jul 17, 2026.
Open?$59.59
High?$60.64
Low?$59.40
Prev. Close?$60.00
Volume?1.6M
Avg. Volume?1.9M
VWAP?$59.73
Rel. Volume?0.85x
Bid / Ask
Bid?$56.47 × 100
Ask?$63.37 × 100
Spread?$6.90
Midpoint?$59.92
Valuation & Ratios
Market Cap?11.6B
Shares Out?193.3M
Float?192.0M
Float %?99.3%
P/E Ratio?43.15
P/B Ratio?1.87
EPS?$1.39
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
Themes
Employees
3.2K
Market Cap
11.6B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1999-07-23
Address
105 DIGITAL DRIVE
NOVATO, CA 94949
Phone: (415) 506-6700
NOVATO, CA 94949
Phone: (415) 506-6700
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?92
Momentum?65
Short Sent.?29
Piotroski F-Score?3/9Weak
Altman Z-Score?4.00Safe
Confidence?63%Moderate
Short InterestHigh
Short % of Float?7.25%Elevated
Short Interest?13.9M
Days to Cover?6.0
Free Float192.0M
Avg Daily Volume2.3M
Settlement Date2026-06-30
Financial Health
Current Ratio?5.81Strong
Quick Ratio?4.20Strong
Cash Ratio?2.80Strong
Debt/Equity?0.23Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?43.2PRICEY▾
Peers100
S&P16
P/B?1.87CHEAP▾
Peers100
S&P78
P/S?3.58FAIR▾
Peers100
S&P43
P/FCF?15.1CHEAP▾
Peers100
S&P74
EV/EBITDA?27.8HIGH▾
Peers100
S&P12
EV/Sales?3.33FAIR▾
Peers100
S&P56
Returns & Efficiency
ROE?4.3%WEAK▾
Peers50
S&P19
ROA?3.1%FAIR▾
Peers50
S&P28
Cash Flow & Enterprise
FCF?$767.1M
Enterprise Value?$10.8B
Fundamentals ratios updated end of day